Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trojan Technologies
USA
- Ownership
- Private
- Development stage
- Other
01
Overview
Trojan Technologies USA is advancing the Antennapedia protein transduction technology for therapeutic delivery in infectious diseases. As of the latest data, the company is preparing for preclinical studies to support an IND (Investigational New Drug) application. No clinical data are yet available for this program.[12]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Protein transduction technologyBiologic
- Industry
- Biotech
02
Partnerships
Trojantec Ltd (technology licensor)
Beyond the preview
Go deeper on Trojan Technologies.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Trojan Technologies.